logo-loader
viewArcadia Biosciences Inc

Arcadia Biosciences joint venture Verdeca gets important approval from Argentina for its HB4 soybeans

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive Investors the health and nutrition company together with Bioceres S.A. has received an important approval from Argentina for their joint venture Verdeca.

Kerkar says the company now has the green light for introduction of their drought-resistant, herbicide-tolerant soybeans HB4 that deliver compelling yield increases despite dry spells.

According to the company, the soybeans provide a real advantage for producers by reducing yield losses, without dispensing with options for weed control.

Quick facts: Arcadia Biosciences Inc

Price: 5.06 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $43.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Perseus Mining reports 'another excellent quarter' with production up and...

Perseus Mining Ltd's (ASX:PRU) (TSE:PRU) (FRA:P4Q) (OTCMKTS:PMNXF) Jeff Quartermaine tells Proactive it's been 'another excellent quarter' for the group. "Production's up about 3% and costs down about 7% quarter on quarter. "This is the 11th consecutive quarter that we've produced very...

8 hours, 41 minutes ago

2 min read